Who are Magnesium sulphate intramuscular's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Neurontin, Magnesium Sulfate, Adjunctive Zonisamide, zonisamide high dose group, Lamictal TM, pregabalin capsules.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/magnesium-sulphate-intramuscular.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Magnesium sulphate intramuscular — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Magnesium sulphate intramuscular (Magnesium sulphate intramuscular) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Anticonvulsant; electrolyte supplement. Area: Obstetrics; Neurology; Cardiovascular.

marketed Anticonvulsant; electrolyte supplement NMDA receptor; voltage-gated calcium channels Obstetrics; Neurology; Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Magnesium sulphate intramuscular (Magnesium sulphate intramuscular) — Nishtar Medical University. Magnesium sulphate acts as a central nervous system depressant and anticonvulsant by blocking N-methyl-D-aspartate (NMDA) receptors and reducing neuromuscular transmission.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Magnesium sulphate intramuscular TARGET	Magnesium sulphate intramuscular	Nishtar Medical University	marketed	Anticonvulsant; electrolyte supplement	NMDA receptor; voltage-gated calcium channels
Neurontin	gabapentin	Generic (originally Parke-Davis/Pfizer)	marketed	Gabapentinoid (anticonvulsant/neuropathic pain agent)	Large neutral amino acids transporter small subunit 1, Adenosine receptor A1, Alpha-2A adrenergic receptor	1993-12-30
Magnesium Sulfate	Magnesium Sulfate	Pfizer	marketed	Electrolyte; anticonvulsant	Neuromuscular junction; motor nerve impulse; acetylcholine release	1981-01-01
Adjunctive Zonisamide	Adjunctive Zonisamide	Eisai Inc.	marketed	Anticonvulsant / Antiepileptic drug	Voltage-gated sodium channels, T-type calcium channels, carbonic anhydrase
zonisamide high dose group	zonisamide high dose group	Eisai Korea Inc.	marketed	Sulfonamide anticonvulsant	Voltage-gated sodium channels, T-type calcium channels, GABA enhancement
Lamictal TM	Lamictal TM	Central Mental Clinic for Outpatients of Baku City	marketed	Anticonvulsant / Mood stabilizer	Voltage-gated sodium channels; glutamate release inhibition
pregabalin capsules	pregabalin capsules	AstraZeneca	marketed	Gabapentinoid; anticonvulsant; anxiolytic	Alpha-2-delta-1 subunit of voltage-gated calcium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Anticonvulsant; electrolyte supplement class)

Nishtar Medical University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Magnesium sulphate intramuscular — Competitive Intelligence Brief. https://druglandscape.com/ci/magnesium-sulphate-intramuscular. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab